Great work from the Oncosil team in Q4, however sales in Q4 a bit behind expectations given recent break even remarks at Webinar.
What then is responsible for recent 100% SP appreciation and continued strength? - certainly not a pump.
Besides recent board addition with PH and capital injection by Pengana, I believe there is something else in the bush.
A bid perhaps?
Do your own research or ask your financial advisor.
Great work from the Oncosil team in Q4, however sales in Q4 a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.010(1.06%) |
Mkt cap ! $13.51M | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | $1.02 | 94.0¢ | $110.7K | 114.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15628 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 1909 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |